FlexTrade Releases Latest Q&A on Best Execution Platform

FlexTrade Releases Latest Q&A on Best Execution Platform

FlexTrade today released their latest Q&A titled: ‘How will MiFID II impact FX execution for the buy-side?’.



The FlexTRADER EMS currently covers Spot FX and NDFs and other FX derivatives. Except for Spot FX, these are derivatives which are in-scope “financial instruments” in MiFID II.

In this latest Q&A, FlexTrade have partnered with the legal firm Simmons & Simmons to respond to commonly asked questions from buy-side users around FlexTrade’s MTF/OTF status.

You can request your copy of ‘How will MiFID II impact FX execution for the buy-side?’  from FlexTrade’s Best Execution Platform, which showcases FlexTrade’s comprehensive approach to trading during MiFID II.

FlexTrade is a global leader in broker-neutral, execution and order management trading systems for equities, FX, options, futures and fixed income. A pioneer in the field, FlexTrade introduced the first trading system that allowed clients to control and customize their proprietary algorithms while maintaining the confidentiality of their trading strategies. Change is the only constant in electronic trading. That's why FlexTrade is continuously upgrading its products and services. All can be tailored to meet the demanding requirements of a global client base of more than a 200 buy- and sell-side firms.
CONTACT
Sales
sales@flextrade.com
516-627-8993
  Company Website
  Linkedin
  Company Blog
  Google +